CELLULAR MECHANISMS OF DRUG TRANSPORT IN CHOROID PLEXUS
Project Number2R01GM042230-09
Former Number2R01GM042230-13
Contact PI/Project LeaderGIACOMINI, KATHLEEN M
Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
Nucleosides (e.g., adenosine) and synthetic nucleoside analogs (e.g.,
cytosine arabinoside (Ara-C) and 2',3'-dideoxyinosine (ddI)) are being
used in the treatment of a wide array of disease states including
cancer, viral infections, and cardiac arrhythmias. The overall goal of
studies proposed in this competitive renewal application is to identify
the structure, function and biological roles of Na+-dependent nucleoside
transporters with particular emphasis on the specific transporters in
the choroid plexus that are vital in the central nervous system (CNS)
disposition and targeting of nucleosides and nucleoside drugs. In
recent exciting studies, the first Na+-dependent nucleoside transporters
were cloned from rat (rPUR and rPYR) and human (hPUR (cloned in this
laboratory) and hPYR) tissues. hPYR and rPYR are pyrimidine-selective
whereas hPUR and rPUR are purine- selective. Initial studies suggest
that these cloned transporters are present in choroid plexus epithelium
and play a role in the CNS targeting of nucleosides and nucleoside
analogs. Novel studies performed in this laboratory with chimeric
transporters have identified, for the first time, the gross structural
domains responsible for the purine and pyrimidine selectivity of rPUR
and rPYR. The specific aims of the proposed studies are: (1) To
determine the functional characteristics hPUR and hPYR in heterologous
expression systems. Particularly, we will investigate the mechanisms of
interactions of synthetic nucleoside analogs which are important in the
treatment of cancer and viral infections; (2) To determine the
functional domains and critical amino acids responsible for purine and
pyrimidine substrate recognition in PUR and PYR; and (3) To localize
rPUR and rPYR to the brush border or basolateral membrane of the choroid
plexus. Briefly, we will perform functional studies in a mammalian
expression system. Site-directed mutagenesis, construction of chimeric
transporters together with molecular modeling will be used to determine
the critical amino acids responsible for substrate selectivity in the
transporters. Studies with antibodies will localize the transporters
in choroid plexus epithelium. These studies will greatly advance our
understanding of the molecular mechanisms involved in nucleoside
transport and the structural elements of nucleoside transporters
critical in purine and pyrimidine discrimination. The information
gained is important in drug design and targeting to the CNS.
No Sub Projects information available for 2R01GM042230-09
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01GM042230-09
Patents
No Patents information available for 2R01GM042230-09
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01GM042230-09
Clinical Studies
No Clinical Studies information available for 2R01GM042230-09
News and More
Related News Releases
No news release information available for 2R01GM042230-09
History
No Historical information available for 2R01GM042230-09
Similar Projects
No Similar Projects information available for 2R01GM042230-09